EMA to be given more power and independence in handling COVID-19 pandemic and future health emergencies. Negotiations between member states and European Parliament are due to begin
Europe’s research labs scrambled to make the best use of their resources and offered remote access for researchers during the pandemic. Some of these changes are set to become a permanent feature
Open letter tells prime minister Boris Johnson to "stand on the right side of history". Meanwhile EU is reluctant to follow the US and back vaccines waiver
Head of EU pharma trade body says waiver would ‘open the door to counterfeit vaccines’ and kill incentives to tackle dangerous virus variants. ‘Who will make the vaccine next time?’ one pharma chief asks
As COVID-19 shows, older people are particularly vulnerable to infectious diseases. IMI’s VITAL project is studying vaccines and immunity in older adults, to figure out the best strategies to keep people healthier for longer.
At first event to be jointly organised by European Innovation Council and European Institute of Innovation and Technology, entrepreneurs call for EU to fill gaps in support and funding their companies need to scale up and be profitable
Relief bill has money to help researchers over the COVID-19 crisis and fill gaps in US response, such as viral genome sequencing and zoonotic disease work. But some say it is a fraction of what is needed for science to recover fully
Universities are caught in the cross fire of the pandemic. While the value of their research has never been more evident, the quality of online learning is questioned. How will university rankings respond?
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.